Oppenheimer initiates Raptor Pharmaceutical At Market Perform

Analysts at Oppenheimer initiated coverage on Raptor Pharmaceutical

with a Market Perform rating. Raptor Pharmaceutical shares have dropped 23.44% over the past 52 weeks, while the S&P 500 index has surged 13.56% in the same period. Raptor Pharmaceutical's shares rose 1.38% to close at $11.01 yesterday.